| Geld/Brief | 3,66 $ / 6,37 $ |
| Spread | +74,04% |
| Schluss Vortag | 4,08 $ |
| Gehandelte Stücke | 475.556 |
| Tagesvolumen Vortag | 1.521.095 $ |
| Tagestief 4,035 $ Tageshoch 4,32 $ | |
| 52W-Tief 4,00 $ 52W-Hoch 10,98 $ | |
| Jahrestief 4,00 $ Jahreshoch 10,75 $ | |
| Umsatz in Mio. | - |
| Operatives Ergebnis (EBIT) in Mio. | -109,26 $ |
| Jahresüberschuss in Mio. | -99,96 $ |
| Umsatz je Aktie | - |
| Gewinn je Aktie | -1,31 $ |
| Gewinnrendite | - |
| Umsatzrendite | - |
| Return on Investment | -37,20% |
| Marktkapitalisierung in Mio. | 342,95 $ |
| KGV (Kurs/Gewinn) | -7,58 |
| KBV (Kurs/Buchwert) | 3,07 |
| KUV (Kurs/Umsatz) | - |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +91,80% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 4,05 $ | -0,74% | 4,08 $ | 22.09.26 | |
| Nasdaq | 4,065 $ | -0,37% | 4,08 $ | 22.09.26 | |
| NYSE | 4,06 $ | -0,25% | 4,07 $ | 22.09.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 22.09.26 | 4,14 | 1,03 M |
| 21.09.26 | 4,08 | 463 T |
| 18.09.26 | 4,20 | 462 T |
| 17.09.26 | 4,18 | 444 T |
| 16.09.26 | 4,16 | 0,57 M |
| 15.09.26 | 4,13 | 263 T |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 4,13 $ | +0,24% |
| 1 Monat | 4,88 $ | -15,16% |
| 6 Monate | 5,65 $ | -26,73% |
| 1 Jahr | 5,31 $ | -22,03% |
| 5 Jahre | - | - |
| Marktkapitalisierung | 342,95 Mio. $ |
| Streubesitz | 7,90% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +7,88% | Paradigm Biocapital Advisors LP |
| +6,43% | Affinity Asset Advisors, LLC |
| +6,37% | RA Capital Management, LLC |
| +6,34% | HHG PLC |
| +6,25% | BlackRock Inc |
| +5,70% | Vestal Point Capital LP |
| +5,64% | Frazier Life Sciences Management, L.P. |
| +4,96% | Vanguard Group Inc |
| +4,81% | Citadel Advisors Llc |
| +4,58% | Orbimed Advisors LLC |
| +4,54% | State Street Corp |
| +3,83% | Vanguard Capital Management, LLC |
| +3,50% | Woodline Partners LP |
| +3,05% | Vanguard Total Stock Mkt Idx Inv |
| +2,97% | Vanguard MStar Total Stk Mkt Idx Invest |
| +2,97% | Vanguard Morn Total Stk Mkt Idx Investor |
| +2,74% | State Street® SPDR® S&P® Biotech ETF |
| +2,71% | Orbimed Advisors, LLC |
| +2,48% | The Goldman Sachs Group Inc |
| +2,41% | Point72 Asset Management, L.P. |
| +2,39% | venBio Select Advisor LLC |
| +2,12% | iShares Russell 2000 ETF |
| +2,05% | Millennium Management LLC |
| +2,02% | Balyasny Asset Management LLC |
| +1,94% | JPMorgan Small Cap Growth A |
| +1,93% | Geode Capital Management, LLC |
| +1,87% | ADAR1 Capital Management LLC |
| +1,64% | Dimensional Fund Advisors, Inc. |
| +1,59% | Suvretta Capital Management, LLC |
| +0,91% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,87% | Janus Henderson Gbl Life Sciences Divers |
| +0,86% | Janus Henderson Global Life Sciences D |
| +0,86% | Janus Henderson Global Life Sciences |
| +0,83% | Fidelity Small Cap Index |
| +0,78% | Janus Global Life Science AUSD |
| +0,78% | Janus Henderson Glb Life Scn I2 USD |
| +0,75% | iShares Russell 2000 Value ETF |
| +0,62% | JPMorgan Small Cap Blend A |
| +0,61% | iShares Biotechnology ETF |
| +0,54% | Biotech Growth Ord |
| +0,53% | Russell 2000 Equity Index Fund B |
| +0,52% | abrdn Life Sciences Investors |
| +0,52% | State St Russell Sm/Mid Cp® Indx SL Cl I |
| +0,51% | Russell 2000 Index Non-Lendable Fund |
| +0,45% | Vanguard Russell 2000 ETF |
| +0,44% | Stt Strt®SPDR®S&PKenshoNwEcosComposETF |
| +0,43% | Fidelity Extended Market Index |
| +0,36% | State St Russell Sm Cap® Idx SL Cl I |
| +0,34% | Fidelity Enhanced Small Cap Core ETF |
| +0,33% | Dimensional US Small Cap ETF |
| +91,673% | Institutionelle Aktionäre |
| +0,424% | Insider Aktionäre |
| +7,903% | Streubesitz |
